Susanna C. Larsson is a Swedish epidemiologist. She is associate professor at the Institute of Environmental Medicine at the Karolinska Institutet, Stockholm, Sweden. [1] She is currently also associated with the Neurology Unit, University of Cambridge, [2] where she is part of a group engaged in a study on the effect of diet on stroke risk. [3] [4] [5]
She graduated from Stockholm University, and Karolinska Institutet, Stockholm, Sweden. She did post-doctoral work at National Institute for Health and Welfare, Helsinki, Finland. She has been lead author for a number of major meta-analyses and reviews. [6]
The Karolinska Institute is a research-led medical university in Solna within the Stockholm urban area of Sweden. The Karolinska Institute is consistently ranked amongst the world's best medical schools, ranking 6th worldwide for medicine in 2021. The Nobel Assembly at the Karolinska Institute awards the Nobel Prize in Physiology or Medicine. The assembly consists of fifty professors from various medical disciplines at the university. The current rector of Karolinska Institute is Ole Petter Ottersen, who took office in August 2017.
Cerebrovascular disease includes a variety of medical conditions that affect the blood vessels of the brain and the cerebral circulation. Arteries supplying oxygen and nutrients to the brain are often damaged or deformed in these disorders. The most common presentation of cerebrovascular disease is an ischemic stroke or mini-stroke and sometimes a hemorrhagic stroke. Hypertension is the most important contributing risk factor for stroke and cerebrovascular diseases as it can change the structure of blood vessels and result in atherosclerosis. Atherosclerosis narrows blood vessels in the brain, resulting in decreased cerebral perfusion. Other risk factors that contribute to stroke include smoking and diabetes. Narrowed cerebral arteries can lead to ischemic stroke, but continually elevated blood pressure can also cause tearing of vessels, leading to a hemorrhagic stroke.
The long-term heavy consumption of alcohol can cause severe detrimental effects. Health effects associated with alcohol intake in large amounts include an increased risk of developing an alcohol use disorder, malnutrition, chronic pancreatitis, erectile dysfunction, heart failure, atrial fibrillation, gastritis, stomach ulcers, alcoholic liver disease, certain types of dementia, and several types of cancer. In addition, damage to the central nervous system and peripheral nervous system can occur from chronic heavy alcohol consumption. There is also an increased risk for accidental injuries, for example, those sustained in traffic accidents and falls. Studies show that individuals with heavy substance use have a much higher risk of having other disorders. A cross-sectional observational study found evidence that people who used substances had the highest risk for five of the disorders studied. However, even light and moderate alcohol consumption increase the risk for developing certain types of cancer. Among women, light drinkers have a four percent increase risk of breast cancer, while moderate drinkers have a 23 percent increase in risk of the disease.
The Mediterranean diet is a diet inspired by the eating habits and traditional food typical of Crete, much of the rest of Greece, and southern Italy in the early 1960s. This differentiates it from Mediterranean cuisine, which occurs naturally in Mediterranean countries and is inherent to them. While inpsired by a specific time and place, the "Mediterranean diet" was later proven and refined based on the results of multiple scientific studies.
Although health benefits have been assumed throughout the history of using Camellia sinensis as a common beverage, there is no high-quality evidence that consuming tea confers significant benefits other than possibly increasing alertness, an effect caused by caffeine in the tea leaves. In clinical research conducted over the early 21st century, tea has been studied extensively for its potential to lower the risk of human diseases, but there is no good scientific evidence to indicate that consuming tea affects any disease or improves health.
In gastronomy, red meat is commonly red when raw and a dark color after it is cooked, in contrast to white meat, which is pale in color before and after cooking. In culinary terms, only flesh from mammals or fowl is classified as red or white. In nutritional science, red meat is defined as any meat that has more of the protein myoglobin than white meat. White meat is defined as non-dark meat from fish or chicken.
Slowly evolving immune-mediated diabetes, or latent autoimmune diabetes in adults (LADA), is a form of diabetes that exhibits clinical features similar to both type 1 diabetes (T1D) and type 2 diabetes (T2D), and is sometimes referred to as type 1.5 diabetes. It is an autoimmune form of diabetes, similar to T1D, but patients with LADA often show insulin resistance, similar to T2D, and share some risk factors for the disease with T2D. Studies have shown that LADA patients have certain types of antibodies against the insulin-producing cells, and that these cells stop producing insulin more slowly than in T1D patients.
A 2017 umbrella review of meta-analyses found that drinking coffee is generally safe within usual levels of intake and is more likely to improve health outcomes than to cause harm at doses of 3 or 4 cups of coffee daily. Exceptions include possible increased risk in women having bone fractures, and a possible increased risk in pregnant women of fetal loss or decreased birth weight. Results were complicated by poor study quality, and differences in age, gender, health status, and serving size.
Vladimir Hachinski is a Canadian clinical neuroscientist and researcher based at the Schulich School of Medicine and Dentistry at Western University. He is also a Senior Scientist at London's Robarts Research Institute. His research pertains in the greatest part to stroke and dementia, the interactions between them and their joint prevention. He and John W. Norris helped to establish the world's first successful stroke unit at Sunnybrook Hospital in Toronto, and, by extension, helped cement stroke units as the standard of care for stroke patients everywhere. He discovered that the control of the heart by the brain is asymmetric, the fight/flight (sympathetic) response being controlled by the right hemisphere and the rest and digest (parasympathetic) response being controlled by the left hemisphere and damage to one key component can lead to heart irregularities and sudden death. This discovery has added fundamental knowledge to how the brain controls the heart and blood pressure and lays the foundation for helping prevent sudden death.
Hans-Olov Adami is a Swedish physician, academic and public health researcher. He established the largest epidemiologic and biostatistics research unit in Sweden, the Department of Medical Epidemiology and Biostatistics at the Karolinska Institutet. He is a former chair of the Department of Epidemiology at the Harvard School of Public Health in Boston, US.
Ami R. Zota is an associate professor at George Washington University Milken School of Public Health, specializing in public and occupational health.
Emma Maria Frans is a postdoctoral researcher in medical epidemiology at Karolinska Institutet in Stockholm and well-known science communicator in Sweden. She is also known for writing the column "Vetenskapskollen" in the newspaper Svenska Dagbladet, where she examines the correctness and scientific accuracy of sensational news and popular science articles.
Douglas F. Easton FMedSci is a British epidemiologist who conducts research on the genetics of human cancers. He is Professor of Genetic Epidemiology and Centre for Cancer Genetic Epidemiology at the University of Cambridge. He founded Cambridge's Cancer Research UK Genetic Epidemiology Unit in 1995, and was a Principal Research Fellow there from 2001 to 2011. He is a Professorial Fellow of Homerton College, Cambridge.
Nancy L. Pedersen is an American genetic epidemiologist. She is Professor of Genetic Epidemiology and the leader of the Swedish Adoption/Twin Study of Aging (SATSA) at the Karolinska Institutet in Stockholm, Sweden. She is known for her research on human twins, much of which is based on the Swedish Twin Registry. This has included research on the genetic basis of Alzheimer's disease and self-confidence.
The Swedish Twin Registry is a twin registry based at the Karolinska Institutet in Stockholm, Sweden. Originally established in the 1960s, it is the largest twin registry in the world. It is widely used for medical research, with about thirty active research projects using data from the study as of 2019. As of 2012, it contained a total of 194,000 twins, 75,000 of whom were of a known zygosity. In principle, it contains records of every twin born in Sweden since 1886.
Miia K. Kivipelto is a Finnish neuroscientist and professor at the University of Eastern Finland and Karolinska Institute in Stockholm. Her research focuses on dementia and Alzheimer's disease.
Danuta Elizabeth Wasserman is a professor of psychiatry and suicidology at Karolinska Institutet in Sweden. She is a public mental health and medical educator.
Ivanka Savic Berglund is a Serbian-Swedish neuroscientist, a professor of neurology and chief physician at the Karolinska Institute in Sweden, and an adjunct professor in the neurology department at the University of California, Los Angeles (UCLA). Savic is best known for her neurophysiology and neuroimaging research relating to epilepsy, sex differences, sexual orientation, gender identity, brain processing of odors and pheromones, and the effects of chronic stress on the brain. Savic is a co-founder of the Stockholm Brain Institute and the editor of several medical books.
Astrid Elsa Fagraeus-Wallbom, born May 30, 1913 in Stockholm, Sweden and died February 24, 1997, was a Swedish immunologist.
Elisabete Weiderpass-Vainio is a Brazilian cancer researcher who is Director of the International Agency for Research on Cancer, a part of the World Health Organization. Her research considers the epidemiology and prevention of cancer.